Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

EClinicalMedicine  – September 24, 2020

Source: OpenAlex

Summary

Please provide the academic research paper you would like me to summarize. Once I have the text, I will craft a professional and engaging summary, strictly within 69-89 words. It will begin with a compelling finding, include specific data (sample sizes, percentages, effect sizes) without p-values, avoid jargon, and omit phrases like "this study." I will naturally incorporate all specified terms, including Psilocybin, Medicine, Adverse effect, Depression, Population, Anxiety, Psychiatry, Hallucinogen, Psychedelics and Drug Studies, Cannabis and Cannabinoid Research, and Chemical synthesis and alkaloids.

Abstract

Carey Turnbull, Heffter Research Institute, NIMH R25 MH060482, NIH UL1 TR001872, River Styx Foundation, Saisei Foundation, Sarlo Foundation, Stupski Foundation, Usona Institute, US Department of Veterans Affairs (Advanced Neurosciences Fellowship and IK2CX001495).

Comments

No comments yet.

Log in to comment